Coloplast A/S (OTCMKTS:CLPBY) Rating Increased to Hold at Hsbc Global Res

Hsbc Global Res upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) from a moderate sell rating to a hold rating in a report issued on Monday,Zacks.com reports.

Coloplast A/S Stock Performance

OTCMKTS:CLPBY opened at $12.60 on Monday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.56 and a current ratio of 0.85. Coloplast A/S has a 12-month low of $10.69 and a 12-month high of $14.34. The stock’s 50 day moving average price is $13.07 and its two-hundred day moving average price is $12.86.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $1.02 billion during the quarter. Coloplast A/S had a return on equity of 31.17% and a net margin of 18.69%. On average, equities research analysts predict that Coloplast A/S will post 0.38 EPS for the current year.

Coloplast A/S Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, December 20th. Stockholders of record on Monday, December 9th will be issued a dividend of $0.2435 per share. The ex-dividend date of this dividend is Monday, December 9th. This is a boost from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s payout ratio is currently 27.27%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.